Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Access Bio Inc

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, a... read more Featured Products: More products

Download Mobile App




Performance of Field Evaluated Malaria Rapid Diagnostic Tests

By LabMedica International staff writers
Posted on 22 Sep 2016
The introduction of malaria rapid diagnostic tests (RDTs) has enhanced quick examination of blood samples from suspected malaria patients; however, it is not clear which RDT is the most appropriate in different endemic areas with mono and mixed infections of different parasites.

Regardless of the setting, RDTs require minimal operator training, and yield highly reproducible test interpretations. RDT results are normally rapidly available when the physician is actively managing patients as the test can be completed in less than 20 minutes. They do not require any instrumentation, electricity, special laboratories, or water and these kits are generally cost-beneficial.

Scientists at the Kenya Medical Research Institute (Nairobi, Kenya) and their colleagues evaluated commercial RDTs for malaria on 500 study participants. The study participants included 290 (58%) children younger than 12 years and the other 210 ranged in age from 13 to 64 year. The 181 male participants were a minority of participants while the majority of the participants were the 319 females. The 196 adult women who were not pregnant comprised 39% of the female population.

The team assessed the performance of BinaxNow, SD Bioline, CareStart Malaria, and First Response. These RDTs were compared to thin and thick blood film microscopy and real time polymerase chain reaction (PCR). Amplification and real-time measurements was performed in the AB 7500 analytical PCR system from Applied Biosystems.

Of the 500 participants recruited, 33% were malaria positive by microscopy while 51.2 % were positive by PCR. Compared to microscopy, the sensitivity of the RDTs to detect malaria parasites was 90.3% to 94.8 %, the specificity was 73.3% to 79.3%, the positive predictive value was 62.2% to 68.8%, and the negative predictive value was 94.3% to 96.8%. Compared to PCR, the sensitivity of the RDTs to detect malaria parasites was 71.1% to 75.4%, the specificity was 80.3% to 84.4 %. The RDTs had a moderate measure of agreement with both microscopy of more than 80.1 % and PCR of more than 77.6 %.

The authors concluded that rapid diagnostic tests can be applied in a number of settings with a great potential for impact on public health where they can significantly improve the quality of malaria case management in areas where expert microscopy or PCR methods are not available. This study demonstrated that CareStart, SD Bioline, BinaxNow, and First Response RDTs performed reasonably well in this endemic region for the detection of Plasmodium falciparum. The study was published on September 7, 2016, in the Malaria Journal.

Related Links:
Kenya Medical Research Institute


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Silver Member
ACTH Assay
ACTH ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.